Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yiling Lu

Showing results (101-110 of 224) with videos related to

Pageof 23
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2010
Dose-dependent induction of distinct phenotypic responses to Notch pathway activation in mammary epithelial cellsMarco Mazzone, Laura M Selfors, John Albeck, et al.
The Journal of Clinical Investigation|August 16, 2013
Predicting time to ovarian carcinoma recurrence using protein markersJi-Yeon Yang, Kosuke Yoshihara, Kenichi Tanaka, et al.
Bioscience Reports|May 14, 2009
ARHI (DIRAS3), an imprinted tumour suppressor gene, binds to importins and blocks nuclear import of cargo proteinsShaoyi Huang, In Soon Chang, Wenbo Lin, et al.
Oncotarget|July 1, 2014
Targeting tyrosine-kinases and estrogen receptor abrogates resistance to endocrine therapy in breast cancerShuying Liu, Xiaolong Meng, Huiqin Chen, et al.
Bioinformatics (Oxford, England)|October 7, 2022
RPPA SPACE: an R package for normalization and quantitation of Reverse-Phase Protein Array dataHuma Shehwana, Shwetha V Kumar, James M Melott, et al.
Cancer Research|December 16, 2014
α-Tubulin acetylation elevated in metastatic and basal-like breast cancer cells promotes microtentacle formation, adhesion, and invasive migrationAmanda E Boggs, Michele I Vitolo, Rebecca A Whipple, et al.
Cancer Research|January 4, 2008
A vascular targeted pan phosphoinositide 3-kinase inhibitor prodrug, SF1126, with antitumor and antiangiogenic activityJoseph R Garlich, Pradip De, Nandini Dey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
Pharmacodynamic markers of perifosine efficacyBryan T Hennessy, Yiling Lu, Enrique Poradosu, et al.
Cancer Research|February 17, 2017
YAP/TAZ-Mediated Upregulation of GAB2 Leads to Increased Sensitivity to Growth Factor-Induced Activation of the PI3K PathwayChao Wang, Chao Gu, Kang Jin Jeong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2010
Functional proteomic analysis of advanced serous ovarian cancer using reverse phase protein array: TGF-beta pathway signaling indicates response to primary chemotherapyMark S Carey, Roshan Agarwal, Blake Gilks, et al.
Pageof 23

Showing results (101-110 of 224) with videos related to

Sort By:
Pageof 23
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2010
Dose-dependent induction of distinct phenotypic responses to Notch pathway activation in mammary epithelial cellsMarco Mazzone, Laura M Selfors, John Albeck, et al.
The Journal of Clinical Investigation|August 16, 2013
Predicting time to ovarian carcinoma recurrence using protein markersJi-Yeon Yang, Kosuke Yoshihara, Kenichi Tanaka, et al.
Bioscience Reports|May 14, 2009
ARHI (DIRAS3), an imprinted tumour suppressor gene, binds to importins and blocks nuclear import of cargo proteinsShaoyi Huang, In Soon Chang, Wenbo Lin, et al.
Oncotarget|July 1, 2014
Targeting tyrosine-kinases and estrogen receptor abrogates resistance to endocrine therapy in breast cancerShuying Liu, Xiaolong Meng, Huiqin Chen, et al.
Bioinformatics (Oxford, England)|October 7, 2022
RPPA SPACE: an R package for normalization and quantitation of Reverse-Phase Protein Array dataHuma Shehwana, Shwetha V Kumar, James M Melott, et al.
Cancer Research|December 16, 2014
α-Tubulin acetylation elevated in metastatic and basal-like breast cancer cells promotes microtentacle formation, adhesion, and invasive migrationAmanda E Boggs, Michele I Vitolo, Rebecca A Whipple, et al.
Cancer Research|January 4, 2008
A vascular targeted pan phosphoinositide 3-kinase inhibitor prodrug, SF1126, with antitumor and antiangiogenic activityJoseph R Garlich, Pradip De, Nandini Dey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
Pharmacodynamic markers of perifosine efficacyBryan T Hennessy, Yiling Lu, Enrique Poradosu, et al.
Cancer Research|February 17, 2017
YAP/TAZ-Mediated Upregulation of GAB2 Leads to Increased Sensitivity to Growth Factor-Induced Activation of the PI3K PathwayChao Wang, Chao Gu, Kang Jin Jeong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2010
Functional proteomic analysis of advanced serous ovarian cancer using reverse phase protein array: TGF-beta pathway signaling indicates response to primary chemotherapyMark S Carey, Roshan Agarwal, Blake Gilks, et al.
Pageof 23